MEI Pharma Inc (MEIP) — Financial Flexibility Index
MEI Pharma Inc (MEIP) has a Financial Flexibility Index of -1.82x as of June 2025. Free cash flow of $-2.46 Million (operating CF $-2.46 Million minus capex $0.00) represents -2% of total liabilities ($1.35 Million). Check MEI Pharma Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MEI Pharma Inc Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for MEI Pharma Inc across 23 annual periods. See MEIP working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for MEI Pharma Inc (2003–2025)
Year-by-year free cash flow to debt coverage for MEI Pharma Inc. For the full company profile including market capitalisation, see market cap of MEI Pharma Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -15.39x | $-20.84 Million | $-20.84 Million | $1.35 Million | ▼ -154.9% |
| 2024 | -6.04x | $-50.47 Million | $-50.47 Million | $8.36 Million | ▼ -1007.7% |
| 2023 | -0.55x | $-52.45 Million | $-52.48 Million | $96.19 Million | ▼ -41.7% |
| 2022 | -0.38x | $-48.27 Million | $-48.75 Million | $125.43 Million | ▼ -63.4% |
| 2021 | -0.24x | $-31.26 Million | $-31.96 Million | $132.74 Million | ▼ -188.1% |
| 2020 | 0.27x | $35.15 Million | $34.26 Million | $131.51 Million | ▲ +131.8% |
| 2019 | -0.84x | $-29.21 Million | $-29.42 Million | $34.73 Million | ▼ -116.1% |
| 2018 | -0.39x | $-21.09 Million | $-21.30 Million | $54.20 Million | ▼ -153.5% |
| 2017 | 0.73x | $3.54 Million | $3.49 Million | $4.87 Million | ▲ +122.4% |
| 2016 | -3.24x | $-17.85 Million | $-17.86 Million | $5.51 Million | ▲ +42.7% |
| 2015 | -5.66x | $-28.05 Million | $-28.07 Million | $4.96 Million | ▼ -34.6% |
| 2014 | -4.20x | $-19.40 Million | $-19.45 Million | $4.62 Million | ▲ +29.6% |
| 2013 | -5.97x | $-10.01 Million | $-10.04 Million | $1.68 Million | ▼ -50.7% |
| 2012 | -3.96x | $-7.03 Million | $-7.08 Million | $1.77 Million | ▼ -45.8% |
| 2011 | -2.72x | $-6.45 Million | $-6.50 Million | $2.37 Million | ▲ +52.4% |
| 2010 | -5.72x | $-10.03 Million | $-10.03 Million | $1.75 Million | ▼ -124.3% |
| 2009 | -2.55x | $-10.55 Million | $-10.55 Million | $4.14 Million | ▲ +23.7% |
| 2008 | -3.34x | $-11.50 Million | $-11.50 Million | $3.44 Million | ▲ +22.2% |
| 2007 | -4.29x | $-10.79 Million | $-10.79 Million | $2.51 Million | ▲ +40.5% |
| 2006 | -7.21x | $-9.09 Million | $-9.09 Million | $1.26 Million | ▼ -267.5% |
| 2005 | -1.96x | $-5.58 Million | $-5.58 Million | $2.84 Million | ▲ +53.0% |
| 2004 | -4.18x | $-7.97 Million | $-7.97 Million | $1.91 Million | ▼ -207.2% |
| 2003 | -1.36x | $-1.84 Million | $-1.84 Million | $1.35 Million | — |